date:Feb 04, 2013
The deal provides Novozymes with all commercial rights to Iogen Bio-Products existing product portfolio, pipeline, facilities and know-how. Novozymes acquires all of Iogen Corporations industrial enzyme business. The acquisition does not include the purchase of assets that relate to Iogen Corporations bioenergy process technologies.
Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for the pulp paper, textile, grain-processing and animal feed